about
Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinomaLympho-vascular invasion in BRCA related breast cancer compared to sporadic controls.HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriersAn oncological view on the blood-testis barrier.Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal CancerPET Studies on P-glycoprotein function in the blood-brain barrier: how it affects uptake and binding of drugs within the CNS.Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approachPositron emission tomography studies on binding of central nervous system drugs and P-glycoprotein function in the rodent brain.P-glycoprotein activity and biological response.Determining sensitivity and specificity of HER2 testing in breast cancer using a tissue micro-array approachObtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: current modalities and future directions.Selecting Potential Targetable Biomarkers for Imaging Purposes in Colorectal Cancer Using TArget Selection Criteria (TASC): A Novel Target Identification Tool.Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.Staging procedures in patients with mucinous borderline tumors of the ovary do not reveal peritoneal or omental disease.Real-time near infrared fluorescence (NIRF) intra-operative imaging in ovarian cancer using an α(v)β(3-)integrin targeted agent.Enhancing surgical vision by using real-time imaging of αvβ3-integrin targeted near-infrared fluorescent agent.Methylation profiles of hereditary and sporadic ovarian cancer.Preclinical characterisation of 111In-DTPA-trastuzumab.Irradiation of rat brain reduces P-glycoprotein expression and function.Molecular profile of ductal carcinoma in situ of the breast in BRCA1 and BRCA2 germline mutation carriers.The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours.Expression of the stem cell marker ALDH1 in the normal breast of BRCA1 mutation carriers.Erratum to: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach.Analysis of biomarker expression in severe endometriosis and determination of possibilities for targeted intraoperative imaging.Quantitative assessment of P-glycoprotein function in the rat blood-brain barrier by distribution volume of [11C]verapamil measured with PET.Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging.Blood-brain barrier dysfunction in parkinsonian midbrain in vivo.Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration.Potentiation of a p53-SLP vaccine by cyclophosphamide in ovarian cancer: a single-arm phase II study.Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study.P-gp and MRP1 expression in parathyroid tumors related to histology, weight and (99m)Tc-sestamibi imaging results.Diagnostic implications of a small-voxel reconstruction for loco-regional lymph node characterization in breast cancer patients using FDG-PET/CT.A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making.89Zr-bevacizumab PET imaging in primary breast cancer.Validation of the 4B5 rabbit monoclonal antibody in determining Her2/neu status in breast cancer.Expression of the stem cell marker ALDH1 in BRCA1 related breast cancer.Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human resultsBorderline tumours of the ovary: Common practice in the NetherlandsPrognostic value of estrogen receptor α and progesterone receptor conversion in distant breast cancer metastasesThe effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer
P50
Q33454083-6CF6E3D7-834D-4036-9F27-987F909A9C35Q33557794-39D137AF-6B49-4A39-ACA1-6CE438F3A1CBQ34586591-8CC60DE5-9404-4B76-9440-53587C46B2ECQ34727714-AFE0ECD2-A6B1-42DB-96A7-BD0E914899D3Q35738875-386660AD-84A7-4117-A76F-5C976612AB40Q35768641-810EBF39-42D1-4BCA-8D1B-1577B4B4C1BCQ35816286-48293B98-1434-4966-80A8-6A22EF6D4701Q36136731-C2B07BEB-28A9-4FBB-8A2D-55A810D6901DQ36206855-B666F36F-7041-4AE1-9941-9FE351CC16CDQ36245435-040C9153-B185-47AA-AB89-4904338939B9Q37358262-C32DD6FA-2BC1-4250-ABFC-91A447E5EB2DQ37860943-5201CB7B-FA12-4063-B463-A2B3C7A182A6Q38037804-C1DB2F9E-31BE-41CD-9EBB-0E00A5C3280AQ39020775-7A34E8B2-E00A-40F8-9E0D-853F5AFB30FEQ39221812-2AA88D44-A5D8-4F8E-B3F7-0ED7FAA7CA5BQ39555319-11EC5ADD-1E66-4D49-8FFB-E51020535806Q39837903-64F4C8B6-DE7A-44D4-9058-997A23DF6735Q40491931-C7610A5C-492D-4B14-BA20-DA84A8045CB6Q41945670-43910C0D-E02F-4412-8AC1-DE87122EBC41Q42455702-A37EA524-E158-4480-963B-A405013F1F55Q42466925-241D680B-9C6E-4213-A53C-DAB74EAA113BQ43002662-7EC5A390-9C35-4AF1-BB58-038A3EA22CCCQ43177951-6C9B29D5-717A-494C-B39A-0CE9820BD83AQ43971673-96CD3BCD-047D-44E0-A902-555304EA2BF9Q44671680-34F41083-7317-4342-9779-3700A1525F0CQ44944204-2DA45D4E-B4D0-465E-8699-3D929F723C04Q45237161-03EA8685-3343-4618-993D-E87C9C8F68DEQ46688887-B150E022-C7E1-459E-BE6F-870EC66BE5C9Q46920170-C08A7447-322F-4855-85FF-B54B3EA7686CQ47128423-781EF12D-F304-491E-A117-5BF59971049DQ47194803-9027FC87-C12D-4136-A6DA-FB88138EEB47Q48230339-C06AAE6B-E099-48C3-9CD5-8DC3CC048AF1Q50868010-24588D79-74F3-4300-B5D6-79919B377DB1Q51012955-E1C300EA-29B1-446E-BDB8-971CC1D8F1F6Q51755659-15C27A33-E6E2-46D4-AE7D-A6BEEE54D639Q55546561-129D9031-EFEF-4FAD-884E-50D4F6B71CF3Q59700416-30C418F0-24CB-4346-B016-CFC96ADA7E46Q60304208-D52FC1E6-91E3-49E9-AD7F-95A972D9B24FQ60529806-126FEAE0-BC4B-4D82-811A-85D3E1158EDFQ84290611-E2A4810E-D25F-4D95-987E-CFDD40E7F251
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Joost Bart
@ast
Joost Bart
@en
Joost Bart
@es
Joost Bart
@sl
type
label
Joost Bart
@ast
Joost Bart
@en
Joost Bart
@es
Joost Bart
@sl
altLabel
Joost Bart
@en
Jos Bart
@en
prefLabel
Joost Bart
@ast
Joost Bart
@en
Joost Bart
@es
Joost Bart
@sl
P1053
A-5642-2013
P106
P1153
7006841823
P21
P31
P3829
P496
0000-0002-0985-071X